Revision Total Hip Replacement Arthroplasty and Hematologic Variables

Seoul National University

Status: Completed

Conditions: Avascular Necrosis of Hip; Degenerative Hip Joint Disease

Treatments: Other: RTHRA group

Study type: Observational

Funder types: Other

Identifiers

NCT02951741

B-1502/288-302

Details and patient eligibility

About

Revision total hip replacement arthroplasty is a surgery having intra- and postoperative substantial blood loss. The investigators will investigate the relationship between the various hematologic variables and postoperative bleeding volume.

Enrollment: 62 patients

Sex: All

Ages: 20 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• revision total hip replacement

Exclusion criteria

• hematologic disease
• anticoagulant medication
• American Society of Anesthesiologists physical status 4 and 5

Trial design

62 participants in 1 patient group

RTHRA group

Description:

patients undergoing revision total hip replacement

Treatment:

Other: RTHRA group